ArticleFrontiers in medicine2025

Treatment of advanced lung adenocarcinoma with EGFR L833V/H835L compound mutations using furmonertinib: two case reports and literature review.

Shize Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.